| | Adjusted HR‡ | 95% CI |
|---|
Age
| | |
20-34 | 1 | |
35-49 | 1.38 | 0.48-3.98 |
≥50 | 3.11* | 1.17-8.26 |
Gender
| | |
Female | 1 | |
Male | 1.14 | 0.44-2.95 |
Body Mass Index
| | |
<18.5 | 1 | |
≥18.5 | 0.49* | 0.25-0.95 |
- *p <0.05.
- †Among cases who had full information at the end of study, cured cases (n = 241) were compared with death (n = 20) and relapse (n = 17) cases.
- ‡Multivariate model includes age, gender and all significant factors from the univariate model (omitted in this paper).
- TI: Treatment interruption, DS: Drug susceptible, Mono/poly/Rif-R: mono or poly-drug resistance that is not matched with the definition of multidrug-resistant tuberculosis; MDR: multidrug-resistant tuberculosis.
